What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Gerald I. Shulman focuses on Endocrinology, Internal medicine, Insulin resistance, Insulin and Type 2 diabetes.
His Endocrinology study focuses mostly on Diabetes mellitus, Carbohydrate metabolism, Glycogen synthase, Glucose clamp technique and Skeletal muscle.
Adipose tissue, Glucose uptake, Glucose transporter, Glycogen and Gluconeogenesis are the subjects of his Internal medicine studies.
His Insulin resistance research includes elements of Nonalcoholic fatty liver disease, Fatty liver, Steatosis and Type 2 Diabetes Mellitus.
Insulin and Offspring are commonly linked in his work.
His Type 2 diabetes research includes themes of Acetyl-CoA carboxylase and Mitochondrion.
His most cited work include:
- Cellular mechanisms of insulin resistance (2308 citations)
- Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. (1798 citations)
- Mitochondrial dysfunction in the elderly: possible role in insulin resistance (1696 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Insulin resistance, Insulin and Type 2 diabetes.
His Internal medicine study frequently draws parallels with other fields, such as Diabetes mellitus.
His study in Insulin receptor, Adipose tissue, Glycogen, Glycogen synthase and Carbohydrate metabolism falls within the category of Endocrinology.
His biological study spans a wide range of topics, including Steatosis, Lipogenesis, Lipid metabolism, Diacylglycerol kinase and Nonalcoholic fatty liver disease.
In his work, Glycogenolysis and Pyruvate carboxylase is strongly intertwined with Gluconeogenesis, which is a subfield of Insulin.
His Mitochondrion research extends to the thematically linked field of Type 2 diabetes.
He most often published in these fields:
- Internal medicine (88.50%)
- Endocrinology (87.58%)
- Insulin resistance (50.46%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (88.50%)
- Endocrinology (87.58%)
- Insulin resistance (50.46%)
In recent papers he was focusing on the following fields of study:
Gerald I. Shulman mainly focuses on Internal medicine, Endocrinology, Insulin resistance, Insulin and Type 2 diabetes.
His Insulin resistance study incorporates themes from Nonalcoholic fatty liver disease, Fatty liver and Steatosis.
The various areas that he examines in his Nonalcoholic fatty liver disease study include Protein kinase B and Glycogen synthase.
Many of his studies involve connections with topics such as Somatostatin and Insulin.
While the research belongs to areas of Type 2 diabetes, he spends his time largely on the problem of Bioinformatics, intersecting his research to questions surrounding Obesity.
His study looks at the relationship between Insulin receptor and topics such as Kinase, which overlap with Signal transduction.
Between 2017 and 2021, his most popular works were:
- Mechanisms of Insulin Action and Insulin Resistance (379 citations)
- Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases (216 citations)
- The integrative biology of type 2 diabetes. (132 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Gerald I. Shulman mainly investigates Insulin resistance, Endocrinology, Internal medicine, Type 2 diabetes and Nonalcoholic fatty liver disease.
Gerald I. Shulman is doing genetic studies as part of his Insulin and Diabetes mellitus and Insulin resistance investigations.
His study involves Steatosis, Lipid metabolism, Gluconeogenesis, Lipolysis and Adipose tissue, a branch of Endocrinology.
Gerald I. Shulman interconnects Glucagon, Adipose triglyceride lipase and Fatty liver in the investigation of issues within Steatosis.
Gerald I. Shulman has researched Type 2 diabetes in several fields, including Pathogenesis, Bioinformatics, Transcriptome, Transcription factor and White adipose tissue.
His Nonalcoholic fatty liver disease study also includes
- Lipogenesis, which have a strong connection to Acetyl-CoA carboxylase and Glycogen synthase,
- Hypertriglyceridemia, which have a strong connection to Lipoprotein, Pharmacology and Metabolic syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
